These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36054157)

  • 1. Response to sequential treatment with prednisolone and vigabatrin in infantile spasms.
    Dzau W; Cheng S; Snell P; Fahey M; Scheffer IE; Harvey AS; Howell KB
    J Paediatr Child Health; 2022 Dec; 58(12):2197-2202. PubMed ID: 36054157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prednisolone or tetracosactide depot for infantile epileptic spasms syndrome? A prospective analysis of data embedded within two randomised controlled trials.
    Osborne JP; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick A; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; O'Callaghan FK
    Eur J Paediatr Neurol; 2023 Jan; 42():110-116. PubMed ID: 36621063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP
    Lancet; 2004 Nov 13-19; 364(9447):1773-8. PubMed ID: 15541450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
    O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
    O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
    Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to treatment and outcomes of infantile spasms in Down syndrome.
    Harvey S; Allen NM; King MD; Lynch B; Lynch SA; O'Regan M; O'Rourke D; Shahwan A; Webb D; Gorman KM;
    Dev Med Child Neurol; 2022 Jun; 64(6):780-788. PubMed ID: 35092693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of High-Dose Steroid Therapy for Infantile Spasms in Children With Trisomy 21.
    Armstrong D; Said RR
    J Child Neurol; 2019 Oct; 34(11):646-652. PubMed ID: 31113280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.
    Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Lux AL; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Arch Dis Child; 2010 May; 95(5):382-6. PubMed ID: 20457702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of infantile spasms.
    Hancock EC; Osborne JP; Edwards SW
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001770. PubMed ID: 23740534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
    Jones K; Snead OC; Boyd J; Go C
    J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in the cost and use of first-line treatments for infantile epileptic spasms syndrome.
    Sánchez Fernández I; Amengual-Gual M; Barcia Aguilar C; Romeu A; Sheikh T; Torres A; Chao J; Jonas R; Gaínza-Lein M; Harini C; Douglass L
    Epilepsia; 2023 Mar; 64(3):630-640. PubMed ID: 36600453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very-High-Dose Prednisolone Before ACTH for Treatment of Infantile Spasms: Evaluation of a Standardized Protocol.
    Eliyan Y; Heesch J; Alayari A; Rajaraman RR; Sankar R; Hussain SA
    Pediatr Neurol; 2019 Oct; 99():16-22. PubMed ID: 31331669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin and high-dose prednisolone therapy for patients with West syndrome.
    Ko A; Youn SE; Chung HJ; Kim SH; Lee JS; Kim HD; Kang HC
    Epilepsy Res; 2018 Sep; 145():127-133. PubMed ID: 29966811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of vigabatrin in patients with infantile spasms.
    Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
    Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin for infantile spasms.
    Mitchell WG; Shah NS
    Pediatr Neurol; 2002 Sep; 27(3):161-4. PubMed ID: 12393124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
    Carmant L
    Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Cosyntropin, Vigabatrin, and Combination Therapy in New-Onset Infantile Spasms in a Prospective Randomized Trial.
    Knupp KG; Coryell J; Singh RK; Gaillard WD; Shellhaas RA; Koh S; Mitchell WG; Harini C; Millichap JJ; May A; Dlugos D; Nickels K; Mytinger JR; Keator C; Yozawitz E; Singhal N; Lockrow J; Thomas JF; Juarez-Colunga E
    J Child Neurol; 2022 Mar; 37(3):186-193. PubMed ID: 35044272
    [No Abstract]   [Full Text] [Related]  

  • 19. What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?
    Desnous B; Lenoir M; Bitton JY; Arbour M; Villeneuve N; Whiting S; Mohammed I; Wirrell EC; Bello-Espinosa L; Ronen GM; Lortie A; Birca A
    Seizure; 2021 Oct; 91():503-506. PubMed ID: 34371246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome.
    Kuchenbuch M; Lo Barco T; Chemaly N; Chiron C; Nabbout R
    Epilepsia; 2024 Feb; 65(2):430-444. PubMed ID: 37872396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.